Context Therapeutics (CNTX) vs IGC Pharma (IGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
IGC Pharma (IGC) has outperformed Context Therapeutics (CNTX) over the past year, losing 31.7% versus a loss of 72.3%. IGC Pharma is the larger company by market cap ($29.2 million vs $28.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTX | IGC |
|---|---|---|
| Share price | $0.3128 | $0.2821 |
| Market cap | $28.74M | $29.16M |
| 1-day change | +0.06% | +0.74% |
| YTD return | -78.73% | 0.00% |
| 1-year return | -72.34% | -31.71% |
| 5-year return | — | -80.82% |
| EPS (TTM) | $-0.48 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.62 | $0.45 |
| 52-week low | $0.297 | $0.24 |
| Distance from 52-week high | -91.36% | -37.31% |
| Average volume | 1.83M | 710.47K |
| Shares outstanding | 91.88M | 103.38M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IGC has outperformed CNTX by 40.6 percentage points over the past year.
CNTX vs IGC FAQ
Which is bigger, Context Therapeutics or IGC Pharma?
IGC Pharma (IGC) is larger, with a market capitalization of $29.16M compared with $28.74M for Context Therapeutics (CNTX).
Which stock has performed better over the past year, CNTX or IGC?
IGC returned -31.71% over the past 12 months, compared with -72.34% for CNTX (price return, excluding dividends). Past performance does not predict future results.
Are Context Therapeutics and IGC Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.